Literature DB >> 31338530

Dose of enteral nutrition and enterocyte biomarker: a circular link?

Gaël Piton1,2, Amélie Le Gouge3,4, Jean Reignier5,6.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 31338530     DOI： 10.1007/s00134-019-05697-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  3 in total

1.  Causal inference in secondary analysis of a randomized controlled trial.

Authors:  Wenchen Li; Shijun Li
Journal:  Intensive Care Med       Date:  2019-07-03       Impact factor: 17.440

2.  Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2).

Authors:  Jean Reignier; Julie Boisramé-Helms; Laurent Brisard; Jean-Baptiste Lascarrou; Ali Ait Hssain; Nadia Anguel; Laurent Argaud; Karim Asehnoune; Pierre Asfar; Frédéric Bellec; Vlad Botoc; Anne Bretagnol; Hoang-Nam Bui; Emmanuel Canet; Daniel Da Silva; Michael Darmon; Vincent Das; Jérôme Devaquet; Michel Djibre; Frédérique Ganster; Maité Garrouste-Orgeas; Stéphane Gaudry; Olivier Gontier; Claude Guérin; Bertrand Guidet; Christophe Guitton; Jean-Etienne Herbrecht; Jean-Claude Lacherade; Philippe Letocart; Frédéric Martino; Virginie Maxime; Emmanuelle Mercier; Jean-Paul Mira; Saad Nseir; Gael Piton; Jean-Pierre Quenot; Jack Richecoeur; Jean-Philippe Rigaud; René Robert; Nathalie Rolin; Carole Schwebel; Michel Sirodot; François Tinturier; Didier Thévenin; Bruno Giraudeau; Amélie Le Gouge
Journal:  Lancet       Date:  2017-11-08       Impact factor: 79.321

3.  Impact of the route of nutrition on gut mucosa in ventilated adults with shock: an ancillary of the NUTRIREA-2 trial.

Authors:  Gaël Piton; Amélie Le Gouge; Noelle Brulé; Benoit Cypriani; Jean-Claude Lacherade; Saad Nseir; Jean-Paul Mira; Emmanuelle Mercier; Michel Sirodot; Jean-Philippe Rigaud; Stéphanie Malaquin; Edouard Soum; Michel Djibre; Stéphane Gaudry; Didier Thévenin; Jean Reignier
Journal:  Intensive Care Med       Date:  2019-05-29       Impact factor: 17.440
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.